Valo Health Appoints Accomplished Executive Peggy Dalicandro as Vice President, Head of Human Resources

LEX­ING­TON, Mass. – (BUSI­NESS WIRE)–Valo Health, Inc. (“Valo”), a biotech­nol­o­gy com­pa­ny focused on trans­form­ing the drug dis­cov­ery and devel­op­ment process using human-cen­tric data and arti­fi­cial intel­li­gence (AI), today announced the appoint­ment of Peg­gy Dal­i­can­dro as Vice Pres­i­dent, Head of Human Resources. In this new­ly cre­at­ed role, Dal­i­can­dro will shape Valo’s human cap­i­tal strat­e­gy, lead tal­ent acqui­si­tion, and sup­port the scal­ing of the company.

“The suc­cess of Valo depends on col­lab­o­ra­tive, tal­ent­ed, and pas­sion­ate peo­ple who con­nect the seams of sci­ence, tech­nol­o­gy, med­i­cine, and human health. We are excit­ed to wel­come Peg­gy to Valo, and we look for­ward to ben­e­fit­ting from her wealth of expe­ri­ence build­ing and expand­ing high-per­form­ing teams,” said Bri­an Alexan­der, CEO of Valo Health and CEO-Part­ner, Flag­ship Pio­neer­ing. ​“As part of our lead­er­ship team, Peg­gy will guide Valo’s con­tin­ued invest­ment in our peo­ple and cul­ture, help­ing us real­ize the full poten­tial of our human-cen­tric approach to AI-enabled drug dis­cov­ery and development.”

At Valo, Dal­i­can­dro is respon­si­ble for lead­ing the glob­al human resources (HR) func­tion and sig­nif­i­cant­ly expand­ing the company’s work­force. She brings more than 20 years of high­ly rel­e­vant HR expe­ri­ence, with a focus on sup­port­ing, grow­ing, and scal­ing busi­ness­es across inno­v­a­tive indus­tries and geographies.

“Valo has a tremen­dous oppor­tu­ni­ty to strength­en its capa­bil­i­ties to dis­cov­er and devel­op bet­ter med­i­cines at greater speed and scale,” said Dal­i­can­dro. ​“I look for­ward to max­i­miz­ing the organization’s poten­tial by devel­op­ing employ­ee-cen­tered pro­grams across the com­pa­ny as it grows.”

Pri­or to join­ing Valo, Dal­i­can­dro led the tal­ent strat­e­gy across five ven­ture orig­i­na­tion busi­ness units at Flag­ship Pio­neer­ing. Her expe­ri­ence includes senior HR roles at Oxford Bio­med­ica Solu­tions, where she was respon­si­ble for the HR func­tion, and Alex­ion, the rare dis­ease sub­sidiary of Astra Zeneca, where she built and led the Peo­ple and Cul­ture team for the US and Ire­land. Dal­i­can­dro also served as the HR lead for Amazon’s Alexa Arti­fi­cial Intel­li­gence team, where she drove the tal­ent strat­e­gy for the Sci­ence and Engi­neer­ing group.

About Valo Health

Valo Health, Inc. is lever­ag­ing arti­fi­cial intel­li­gence (AI) and advanced ana­lyt­ics to bet­ter learn from the patient expe­ri­ence to dis­cov­er and devel­op bet­ter med­i­cines at greater speed and scale. The company’s Opal Com­pu­ta­tion­al Plat­form™ is a human-cen­tric, AI-dri­ven drug devel­op­ment engine that uses AI to iden­ti­fy and val­i­date nov­el drug tar­gets, using real-world data and human mod­els to rapid­ly dis­cov­er and devel­op small mol­e­cule ther­a­pies against those tar­gets with more pre­dictable safe­ty and effi­ca­cy. Found­ed by Flag­ship Pio­neer­ing and head­quar­tered in Lex­ing­ton, Mass., Valo also has offices in New York, N.Y. and Tel Aviv, Israel. To learn more, vis­it val​o​health​.com.

Con­tacts

Corey Carmichael
(862) 260‑7929
corey.​carmichael@​smithsolve.​com